Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: An analysis of 1309 cases in a 15-year national survey

Hepatology Research

Volumn 30, Issue 3, 2004, Pages 155-161

  Sato, Shunichi ^a   Suzuki, Kazuyuki ^a   Takikawa, Yasuhiro ^a   Endo, Ryujin ^a   Omata, Masao ^b  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Drug induced hepatitis; Fulminant hepatitis; Hepatitis A virus; Hepatitis B virus; Non A hepatitis; Non B hepatitis

Indexed keywords

ANTICOAGULANT AGENT; CHARCOAL; CYCLOSPORIN; DRUG; GLUCAGON; GLUCOCORTICOID; HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; INSULIN; INTERFERON; PROSTAGLANDIN; VIRUS DNA;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG ABUSE; ENZYME IMMUNOASSAY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH SURVEY; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS NON A NON B; HEPATITIS VIRUS NON A NON B; HUMAN; INCIDENCE; INFECTION; JAPAN; KIDNEY FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; QUESTIONNAIRE; RADIOIMMUNOASSAY; SEXUAL TRANSMISSION; SURVIVAL RATE; TOXIC HEPATITIS; VIRUS PATHOGENESIS;

EID: 10644272505     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.08.003     Document Type: Article

References (44)

1. F.V. Shiødt E. Atillasoy O. Shakil et al. Etiology and outcome for 295 patients with acute liver failure in United States Liv Transplant Surg 5 1999 23-34
2. B.N. Tandon Y.K. Joshi M. Tandon Acute liver failure. Experience with 145 patients J Clin Gastroenterol 8 1986 664-668
3. G. Paraevangelos N. Tassopoulos A. Roumeliotou-Karayannis C. Richardson Etiology of fulminant viral hepatitis in Greece Hepatology 4 1984 369-372
4. M. McNeil J.F. Hoy M.J. Richards et al. Aetiology of fatal viral hepatitis in Melbourne. A retrospective study Med J Aust 141 1984 637-640
5. J. Rakela S.M. Lange J. Ludwig W. Baldus FH: Mayo clinic experience with 34 cases Mayo Clin Proc 60 1985 289-292
6. E. Christensen A. Bremmelgaard M. Bahnsen P.B. Andreasen N. Tygstrup Prediction of fatality in fulminant hepatic failure Scand J Gastroenterol 19 1984 90-96
7. J. Bernuau A. Goudeau T. Poynard et al. Multivariate analysis of prognostic factors in FH B Hepatology 6 1986 648-651
8. J.G. O'Grady Alexander GJM K.M. Hayllar R. Williams Early indicators of prognosis in fulminant hepatic failure Gastroenterology 97 1989 439-445
9. E. Frohburg E. Stolzel K. Lecz J-H. Schafer L.C. Tung E-O. Riechen Prognostic indicators in fulminant hepatic failure Z Gastroenterol 30 1992 571-575
10. A.C. Anand P. Nightingale J.M. Neuberger Early indicators of prognosis in fulminant hepatic failure: An assessment of King's criteria J Hepatol 26 1997 62-68
11. Fujiwara K. Japanese national survey of FH in 2000. The 2001 Annual Report of Research Group of Intractable Hepatitis. Tokyo: The Ministry of Health and Welfare of Japan 2002 87-96 (in Japanese)
12. W.M. Lee Acute liver failure Semin Liver Dis 23 2003 217-226
13. The Proceedings of the 12th Inuyama Symposium Hepatitis Type A FH Tokyo: Chugai Igaku-sha 1982 (in Japanese)
14. Y. Takahashi M. Shimizu The study group of FH. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicenter study J Gastroenterol Hepatol 6 1991 159-164
15. C. Trey C.S. Davidson The management of fulminant hepatic failure In: H. Popper F. Schaffner (Eds.) Progress in Liver Disease vol. III 1970 Grune & Stratton New York 282-298
16. Y. Takahashi Acute hepatic failure in special relation to treatment Jpn J Med 22 1983 140-145
17. P. Caraceni D.H. Van Thiel Acute liver failure Lancet 345 1995 163-169
18. C. Trey L. Lipworth C.S. Dabidson Parameters influencing survival in the first 318 patients reported to the fulminant hepatic failure surveillance study Gastroenterology 58 1970 306
19. J.T. Horney J.T. Galambos The liver during and after fulminant hepatitis Gastroenterology 73 1977 639-645
20. Y. Kita K. Umeshita M. Gotoh et al. Quality of life in adult Japanese patients undergoing liver transplants overseas Transpl Proc 28 1996 1934-1936
21. A. Humar Donor and recipient outcomes after adult living donor liver transplantation Liv Transpl 9 Suppl 2 2003 S42-S44
22. M. Yoshiba K. Inoue K. Sekiyama et al. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure Artif Organs 11 1996 1169-1172
23. T. Sadahiro H. Hirasawa S. Oda et al. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure Crit Care Med 29 2001 1386-1392
24. L.L. Kjaergard J. Liu B. Als-Nielsen et al. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic review JAMA 289 2003 217-222
25. S.M. Lemon N.L. Gates T.E. Simms W.H. Bancroft IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus J Infect Dis 143 1981 803-809
26. T.L. Wright D. Manish C. Combs et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis Lancet 339 1992 952-955
27. K. Fukai O. Yokosuka K. Fujiwara et al. Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: Analyses by nucleic acid amplification method J Infect Dis 178 1989 325-333
28. A.S.F. Lok R.H.S. Liang E.K.W. Chiu K-L. Wong T-K. Chan D. Todd Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy Gastroenterology 100 1991 182-188
29. B.K. Bang C.W. Yang S.A. Yoon et al. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients Nephron 70 1995 397-401
30. F. Omata H. Ide T. Ito Y. Shibayama H. Takahashi F. Ueno Interferon therapy for FH associated with precore region mutation in hepatitis B virus carrier Am J Gastroenterol 91 1996 1673-1675
31. Japanese Red Cross Non-A, non-B hepatitis Research, Group Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis Lancet 338 1991 1040-1041
32. G.B. Schreiber M.P. Busch S.H. Kleinman et al. The risk of transfusion-transmitted viral infections New Engl Med 334 1996 1685-1690
33. Japanese Red Cross NAT Screening Group Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors Jpn J Infect Dis 53 2000 116-123
34. K. Minegishi A. Yoshikawa S. Kishimoto et al. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening Vox Sang 84 2003 287-291
35. T. Eto K. Shiraki National project on the prevention of mother-to-infant infection by hepatitis B virus in Japan Acta Paedatr Jpn 31 1989 681-684
36. H. Yoshizawa Blood screening to prevent post-transfusion hepatitis in Japan: Effective for prevention as well as revealing the epidemiology of HBV and HCV infection in healthy subjects Int Hepatol Commun 5 1996 79-87
37. Y. Muto J. Sugihara H. Ohnishi H. Moriwaki K. Nishioka Anti-hepatitis C virus antibody presents in fulminant hepatic failure Gastroenterol Jpn 25 1990 32-35
38. T.L. Wright H. Hsu E. Donegan et al. Hepatitis virus not found in fulminant non-A, non-B hepatitis Ann Intern Med 115 1991 111-112
39. M. Yoshiba H. Okamoto S. Mishiro Detection of the GBV-C hepatitis virus genome in serum from patients with FH of unknown aetiology Lancet 346 1995 1131-1132
40. T. Kuroki S. Nishiguchi M. Tanaka M. Enomoto K. Kobayashi Does GBV-C cause FH in Japan? Lancet 347 1996 908
41. H. Okamoto T. Nishizawa N. Kato et al. Molecular cloning and characterization of novel DNA virus (TTV) associated with post-transfusion hepatitis of unknown etiology Hepatol Res 10 1998 1-16
42. M. Yoshiba K. Dehara K. Inoue H. Okamoto M. Mayumi Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan Hepatology 19 1994 829-835
43. P.Y. Kwo G.G. Schlauder H.A. Carpenter et al. Acute hepatitis E by a new isolate acquired in the United States Mayo Clin Proc 72 1997 1133-1136
44. K. Suzuki T. Aikawa H. Okamoto Fulminant hepatitis E in Japan N Engl J Med 347 2002 1456